BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7460483)

  • 1. Cimetidine clearance and bioavailability in hepatic cirrhosis.
    Sonne J; Poulsen HE; Døssing M; Larsen NE; Andreasen PB
    Clin Pharmacol Ther; 1981 Feb; 29(2):191-7. PubMed ID: 7460483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered disposition and availability of cimetidine in liver cirrhotic patients.
    Gugler R; Müller-Liebenau B; Somogyi A
    Br J Clin Pharmacol; 1982 Sep; 14(3):421-30. PubMed ID: 7126415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral and intravenous pharmacokinetics of cimetidine in liver cirrhosis.
    Okolicsanyi L; Venuti M; Orlando R; Lirussi F; Nassuato G; Benvenuti C
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):482-7. PubMed ID: 7141756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cimetidine disposition in patients with Laennec's cirrhosis during multiple dosing therapy.
    Cello JP; Oie S
    Eur J Clin Pharmacol; 1983; 25(2):223-9. PubMed ID: 6628505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of cimetidine in ascitic cirrhotics].
    Albin H; Couzigou P; Vinçon G; Péhourcq F; Fleury B; Béraud C
    Gastroenterol Clin Biol; 1983 Mar; 7(3):251-5. PubMed ID: 6852412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cimetidine kinetics and dynamics in patients with severe liver disease.
    Villeneuve JP; Fortunet-Fouin H; Arsène D
    Hepatology; 1983; 3(6):923-7. PubMed ID: 6629322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and bioavailability of cimetidine in gastric and duodenal ulcer patients.
    Somogyi A; Rohner HG; Gugler R
    Clin Pharmacokinet; 1980; 5(1):84-94. PubMed ID: 7363531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of cimetidine in advanced cirrhosis.
    Grahnén A; Jameson S; Lööf L; Tyllström J; Lindström B
    Eur J Clin Pharmacol; 1984; 26(3):347-55. PubMed ID: 6734697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of cimetidine and its sulphoxide metabolite in patients with normal and impaired renal function.
    Larsson R; Erlanson P; Bodemar G; Walan A; Bertler A; Fransson L; Norlander B
    Br J Clin Pharmacol; 1982 Feb; 13(2):163-70. PubMed ID: 7059413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability of cimetidine in man.
    Walkenstein SS; Dubb JW; Randolph WC; Westlake WJ; Stote RM; Intoccia AP
    Gastroenterology; 1978 Feb; 74(2 Pt 2):360-5. PubMed ID: 620910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of bioavailability and pharmacokinetics of cimetidine in subjects with normal and impaired renal function.
    Guay DR; Matzke GR; Bockbrader HN; Dancik J
    Clin Pharm; 1983; 2(2):157-62. PubMed ID: 6883944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of cimetidine after single doses and during continuous treatment.
    Bodemar G; Norlander B; Walan A
    Clin Pharmacokinet; 1981; 6(4):306-15. PubMed ID: 7249489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability and pharmacokinetics of cimetidine.
    Grahnén A; von Bahr C; Lindström B; Rosén A
    Eur J Clin Pharmacol; 1979 Nov; 16(5):335-40. PubMed ID: 520401
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatic encephalopathy and altered cimetidine kinetics.
    Ziemniak JA; Bernhard H; Schentag JJ
    Clin Pharmacol Ther; 1983 Sep; 34(3):375-82. PubMed ID: 6883913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cimetidine administration and tubular creatinine secretion in patients with compensated cirrhosis.
    Sansoè G; Ferrari A; Castellana CN; Bonardi L; Villa E; Manenti F
    Clin Sci (Lond); 2002 Jan; 102(1):91-8. PubMed ID: 11749665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetics of H2 receptor blocking agents in compensated liver cirrhosis.
    Okolicsányi L; Venuti M; Strazzabosco M; Iemmolo RM; Nassuato G; Orlando R; Lirussi F
    Acta Physiol Hung; 1984; 64(3-4):393-400. PubMed ID: 6099684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The absorption of cimetidine before and during maintenance treatment with cimetidine and the influence of a meal on the absorption of cimetidine--studies in patients with peptic ulcer disease.
    Bodemar G; Norlander B; Fransson L; Walan A
    Br J Clin Pharmacol; 1979 Jan; 7(1):23-31. PubMed ID: 760739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of phenobarbital treatment on cimetidine kinetics.
    Somogyi A; Thielscher S; Gugler R
    Eur J Clin Pharmacol; 1981; 19(5):343-7. PubMed ID: 7238562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steady-state kinetics and dosage requirements of cimetidine in renal failure.
    Larsson R; Norlander B; Bodemar G; Walan A
    Clin Pharmacokinet; 1981; 6(4):316-25. PubMed ID: 7249490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of cimetidine disposition in the aged.
    Ritschel WA
    Methods Find Exp Clin Pharmacol; 1983; 5(4):255-62. PubMed ID: 6888088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.